During the past decade, University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Canadian Department of National Defense" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Defence Research and Development Canada" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute" are "Brain Injuries, Traumatic" (1 trials) and "Shock, Traumatic" (1 trials). Many other conditions were trialed in "University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute" in a lesser frequency.

Most popular intervention types in "University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "0.9% Normal Saline (NS)" (1 trials), "0.9% normal saline" (1 trials), "7.5% Hypertonic Saline (HS)" (1 trials), "7.5% Hypertonic Saline in 6% Dextran-70 (HSD)" (1 trials) and "7.5% hypertonic saline (HS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".